United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$56Mraised across 4 rounds since 2008, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by equityhelpdesk.comSEC filing: $28M sold, first sale Apr 2011
From a historical funding recordSEC filing: $28M sold, first sale Apr 2011
From a historical funding record
From the SEC filings it signed: 3 on the team.
On the board, as filediAndrew Alexander LoC.K. Alexander ChengHongbo Alexander LuLee Alexander TingNisa Alexander LinSandy Alexander Chau
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Qiming Venture Partners
CDIB Capital
OrbiMedLilly Asia VenturesHarbinger Ventures
CID Group
Majuven
Argonaut Private EquityMissing a round, or an investor who was in one? Tell us.
Crown Bioscience's investors include Qiming Venture Partners, CDIB Capital, OrbiMed, Lilly Asia Ventures and Harbinger Ventures, and 3 more on record.
Crown Bioscience has raised $56M across 4 rounds since 2008. One round did not disclose an amount, so the total is a floor.
Crown Bioscience's most recent round was a Series D of $27M in May 2014.
Crown Bioscience's largest round on record is $29M (Series C), in May 2011.
Crown Bioscience's first round on record, in Jan 2008, was backed by Qiming Venture Partners and Harbinger Ventures.
Crown Bioscience's latest named round is a Series D, in May 2014.
Crown Bioscience is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
